Cytomx Therapeutics, Inc. · NASDAQ:CTMX
Orbimed Advisors LLC's stake in Cytomx Therapeutics, Inc. fell to 2.10% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Orbimed Advisors LLC's stake in Cytomx Therapeutics, Inc. fell to 2.10%, 3,525,650 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 2.10%
- Shares
- 3,525,650
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| OrbiMed Advisors LLC | 2.10% | 3,525,650 |
Source
Related
- Cytomx Therapeutics, Inc.
- Orbimed Advisors LLC
- Cytomx Therapeutics, Inc. shareholders
- Schedule 13G · Orbimed Advisors LLC · Aug 14, 2025
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026